Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Evaluation of a Psychoeducation Program in Individuals Diagnosed With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03865186
Recruitment Status : Completed
First Posted : March 6, 2019
Last Update Posted : March 6, 2019
Sponsor:
Information provided by (Responsible Party):
Elif Aşık, Kırıkkale University

Brief Summary:
This study was conducted to explore the effect on social functionality of the psychoeducation program organized to guide individuals diagnosed with schizophrenia to identifying and recognize emotions in facial expressions. half of participants were assessed the psychoeducation program. other half of participants were used only measurement tests.

Condition or disease Intervention/treatment Phase
Schizophrenia Behavioral: Psychoeducation Program Behavioral: no intervention Not Applicable

Detailed Description:

The difficulties those diagnosed with schizophrenia have with facial identification and identifying emotions are closely associated with the adverse symptoms of the illness. Those diagnosed with schizophrenia need to be helped in forming interpersonal relations so that they can gain the skills needed to live in society.

ın this study the investigators prepared a psychoeducation program for individuals diagnosed with schizophrenia. The program titled, "Psychoeducation Program for Emotion Identification and Expression in Those Diagnosed with Schizophrenia" was conducted with the patients in the intervention groups once a week for ten weeks. On the other hand there were a control group which weren't be applied any intervention. The investigators applied some tests to intervention and control group three times ( before intervention, after intervention and three months after intervention). This study was conducted at three Community Mental Health Centers (CMHC's). The patients who met the study inclusion criterias were determined in these centers. Randomized psychoeducation and control groups were formed from these patients.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 42 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: This study was of quasi-experimental (pretest-posttest, with a control group) design.
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: An Evaluation of a Psychoeducation Program for Emotion Identification and Expression in Individuals Diagnosed With Schizophrenia
Actual Study Start Date : January 1, 2015
Actual Primary Completion Date : October 30, 2015
Actual Study Completion Date : July 15, 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia

Arm Intervention/treatment
Experimental: intervention group
The program titled, "Psychoeducation Program for Emotion Identification and Expression in Those Diagnosed with Schizophrenia" was conducted with the patients in the intervention groups once a week for ten weeks.
Behavioral: Psychoeducation Program
The program titled, "Psychoeducation Program for Emotion Identification and Expression in Those Diagnosed with Schizophrenia" was conducted with the patients in the intervention groups once a week for ten weeks.

Experimental: control group
no intervention was applied to the control group
Behavioral: no intervention



Primary Outcome Measures :
  1. Facial Emotion Identification [ Time Frame: 15 minutes ]
    Facial Emotion Identification Test (FEIT) The test is in the form of a slide presentation of 19 black-and-white facial photographs displaying expressions of different emotions. Correct answers are rated 1, errors are scored 0. The highest possible score on the test is 19

  2. Facial Emotion Discrimination [ Time Frame: 20 minutes ]
    Facial Emotion Discrimination Test (FEDT) This consists of 30 pairs of black-and-white photographs depicting six main emotional states (happiness, sadness, anger, fear, surprise, embarrassment). The participant is asked to differentiate the photographs in each pair, determining whether the two facial expressions are the same or different. If the answer is correct, it is scored 1; if wrong, the score is 0. The highest possible score on the test is 30


Secondary Outcome Measures :
  1. Personal and Social Performance [ Time Frame: 20 minutes ]
    Personal and Social Performance Test (PSP) This is a 6-item Likert-type ranked assessment of four dimensions.The patient is first evaluated on the basis of the four dimensions and then the scores in these areas are entered into the score sheet on the basis of 10-point ranges from 10-100 according to the PSP assessment guidelines, assigning the patient a total PSP score. The higher scores indicate better functionality



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of schizophrenia according to DSM-IV
  • over the age of 18

Exclusion Criteria:

  • having cominication problems
  • having another psychiatric disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03865186


Sponsors and Collaborators
Kırıkkale University
Investigators
Layout table for investigator information
Study Director: Gül Ünsal, PhD Marmara University

Publications:

Layout table for additonal information
Responsible Party: Elif Aşık, principal investigator, Kırıkkale University
ClinicalTrials.gov Identifier: NCT03865186     History of Changes
Other Study ID Numbers: EAsik
First Posted: March 6, 2019    Key Record Dates
Last Update Posted: March 6, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: this study manuscript sended to an academic journal

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Elif Aşık, Kırıkkale University:
Cognition
facial expression
facial recognition
psychiatric nursing
psychoeducation
schizophrenia
Additional relevant MeSH terms:
Layout table for MeSH terms
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders